跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 77 条关于
“Pkd2”
全部
77
临床试验
44
药物
21
机构
1
资讯
11
去年
Novartis Acquires Regulus Therapeutics for $800M, Expanding Kidney Disease Portfolio
10个月前
Helex Secures $3.5M Seed Funding to Develop Non-Viral Gene Therapy for Polycystic Kidney Disease
12个月前
USC Scientists Create Most Advanced Lab-Grown Kidney Structures with Real Function for Disease Modeling
去年
Regulus Therapeutics' Farabursen Shows Promise in ADPKD Phase 1b Trial and Gains FDA Agreement on Phase 3 Design
去年
Sitryx Launches Phase 1 Trial of Novel Oral PKM2 Modulator for Atopic Dermatitis
去年
PYC Therapeutics' PKD Drug, PYC-003, Enters Human Clinical Trials
3天前
FDA Grants RMAT Designation to Tenaya's TN-401 Gene Therapy for PKP2-Associated ARVC
11个月前
Sitryx Receives FDA Clearance for First-in-Class PKM2 Modulator SYX-5219 in Atopic Dermatitis
去年
Rocket Pharmaceuticals Advances Gene Therapy Pipeline with Key Updates on Danon Disease and PKP2-ACM Programs
8天前
FDA Clears Quantum BioPharma's IND for Lucid-MS, a First-in-Class PAD2 Inhibitor, in Phase 2 Multiple Sclerosis Trial
第 1 页,共 2 页
上一页
下一页